Literature DB >> 33633682

Ethnicity/Race and Age-Specific Variations of Serum AMH in Women-A Review.

Alexander M Kotlyar1, David B Seifer1.   

Abstract

Purpose of Review: In this review, we summarize ethnic/race- and age-related variation in AMH and discuss the underpinnings behind these differences. Recent findings: Anti-mullerian hormone (AMH) has become a widely used method of ovarian reserve testing over the last 15 years. Numerous studies have shown substantial ethnic/race and age-related differences. When compared to age-matched Caucasian women, AMH levels tend to be lower in black and Hispanic women. Chinese women tend to have significantly greater AMH levels prior to age 25 than Caucasian women. When considering subpopulations within ethnicities, at least one study noted lower AMH levels among Maya women compared to other Hispanic women. Age exhibits a positive trend with AMH up until at least 25 years of age with a consistent decline after 34 years of age extending to menopause. Summary: AMH levels are highly variable among ethnicities and race with higher age-matched levels typically seen in Caucasian women. Age does not exhibit a consistent linear relationship with AMH, but a consistent decline is seen starting in the third decade of life and proceeding to menopause.
Copyright © 2021 Kotlyar and Seifer.

Entities:  

Keywords:  AMH; age; age-specific AMH levels; ethnicity; ovarian reserve; race

Mesh:

Substances:

Year:  2021        PMID: 33633682      PMCID: PMC7900163          DOI: 10.3389/fendo.2020.593216

Source DB:  PubMed          Journal:  Front Endocrinol (Lausanne)        ISSN: 1664-2392            Impact factor:   5.555


  53 in total

1.  Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women.

Authors:  Carlos Iglesias; Manish Banker; Nalini Mahajan; Leyre Herrero; Marcos Meseguer; Juan A Garcia-Velasco
Journal:  Fertil Steril       Date:  2014-04-29       Impact factor: 7.329

2.  Association of anti-mullerian hormone levels with obesity in late reproductive-age women.

Authors:  Ellen W Freeman; Clarisa R Gracia; Mary D Sammel; Hui Lin; Lony Chong-Leong Lim; Jerome F Strauss
Journal:  Fertil Steril       Date:  2006-11-15       Impact factor: 7.329

3.  Circulating vitamin D correlates with serum antimüllerian hormone levels in late-reproductive-aged women: Women's Interagency HIV Study.

Authors:  Zaher O Merhi; David B Seifer; Jeremy Weedon; Oluwatoyin Adeyemi; Susan Holman; Kathryn Anastos; Elizabeth T Golub; Mary Young; Roksana Karim; Ruth Greenblatt; Howard Minkoff
Journal:  Fertil Steril       Date:  2012-04-10       Impact factor: 7.329

4.  Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles.

Authors:  David B Seifer; David T MacLaughlin; Benjamin P Christian; Bo Feng; Robert M Shelden
Journal:  Fertil Steril       Date:  2002-03       Impact factor: 7.329

5.  Value of antimüllerian hormone as a prognostic indicator of in vitro fertilization outcome.

Authors:  David E Reichman; Dan Goldschlag; Zev Rosenwaks
Journal:  Fertil Steril       Date:  2014-02-01       Impact factor: 7.329

6.  Ethnicity and assisted reproductive technologies.

Authors:  Alicia Armstrong; Torie C Plowden
Journal:  Clin Pract (Lond)       Date:  2012-11-01

7.  The endocrine and follicular growth dynamics throughout the menstrual cycle in women with consistently or variably elevated early follicular phase FSH compared with controls.

Authors:  C H de Koning; J McDonnell; A P N Themmen; F H de Jong; R Homburg; C B Lambalk
Journal:  Hum Reprod       Date:  2008-03-28       Impact factor: 6.918

8.  Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment.

Authors:  Christien Weenen; Joop S E Laven; Anne R M Von Bergh; Mark Cranfield; Nigel P Groome; Jenny A Visser; Piet Kramer; Bart C J M Fauser; Axel P N Themmen
Journal:  Mol Hum Reprod       Date:  2004-02       Impact factor: 4.025

9.  Antral follicle count (AFC) and serum anti-Müllerian hormone (AMH) are the predictors of natural fecundability have similar trends irrespective of fertility status and menstrual characteristics among fertile and infertile women below the age of 40 years.

Authors:  Haroon Latif Khan; Shahzad Bhatti; Samina Suhail; Rohina Gul; Aisha Awais; Humaira Hamayun; Farah Enver; Sana Abbas; Zahira Hassan; Rameen Nisar; Saba Sardar; Warda Asif
Journal:  Reprod Biol Endocrinol       Date:  2019-02-11       Impact factor: 5.211

Review 10.  Potential mechanisms for racial and ethnic differences in antimüllerian hormone and ovarian reserve.

Authors:  Reshef Tal; David B Seifer
Journal:  Int J Endocrinol       Date:  2013-11-21       Impact factor: 3.257

View more
  5 in total

1.  Long-term antimüllerian hormone patterns differ by cancer treatment exposures in young breast cancer survivors.

Authors:  Beth Zhou; Brian Kwan; Milli J Desai; Vinit Nalawade; Kathryn J Ruddy; Paul C Nathan; Henry J Henk; James D Murphy; Brian W Whitcomb; H Irene Su
Journal:  Fertil Steril       Date:  2022-02-23       Impact factor: 7.490

2.  Association of oral contraceptives and tubal ligation with antimüllerian hormone.

Authors:  Christine R Langton; Brian W Whitcomb; Alexandra C Purdue-Smithe; Lynnette L Sievert; Susan E Hankinson; JoAnn E Manson; Bernard A Rosner; Elizabeth R Bertone-Johnson
Journal:  Menopause       Date:  2021-12-06       Impact factor: 2.953

3.  Age-Specific Distribution of Serum Anti- Müllerian Hormone and Antral Follicle Count in Indian Infertile Women.

Authors:  Mahmood Dhahir Al-Mendalawi
Journal:  J Hum Reprod Sci       Date:  2022-03-31

4.  Study protocol for a randomised controlled trial on the use of intraoperative ultrasound-guided laparoscopic ovarian cystectomy (UGLOC) as a method of fertility preservation in the management of benign ovarian cysts.

Authors:  Lorraine S Kasaven; Benjamin P Jones; Sadaf Ghaem-Maghami; Jan Yvan Jos Verbakel; Mona El-Bahrawy; Srdjan Saso; Joseph Yazbek
Journal:  BMJ Open       Date:  2022-07-14       Impact factor: 3.006

5.  An Individualized Recommendation for Controlled Ovary Stimulation Protocol in Women Who Received the GnRH Agonist Long-Acting Protocol or the GnRH Antagonist Protocol: A Retrospective Cohort Study.

Authors:  Ming-Xing Chen; Xiang-Qian Meng; Zhao-Hui Zhong; Xiao-Jun Tang; Tian Li; Qian Feng; Enoch Appiah Adu-Gyamfi; Yan Jia; Xing-Yu Lv; Li-Hong Geng; Lin Zhu; Wei He; Qi Wan; Yu-Bin Ding
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-22       Impact factor: 6.055

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.